The Chinese Pharmacopoeia 2005

Overview

Prepared in accordance with the principles and design plan decided by the Eighth Chinese Pharmacopoeia Commission and its Secretariat over more than two years, the 2005 edition of the Pharmacopoeia of the People's Republic of China—known as The Chinese Pharmacopoeia 2005 or in abbreviation as Ch. P 2005—features considerable revisions and improvements. This is the eighth edition published since the founding of the People's Republic of China.

In the latest edition, significant changes can be found in General Notices, Requirements of Monographs, General Requirements for Preparations in Appendices, and new testing methods. Appendices have been updated to include advanced technologies and experimental methods widely adopted in China and abroad for international drug quality control. Monographs admitted to The Chinese Pharmacopoeia 2005 follow the principle of "safety for use, reliability of therapeutic effect, feasibility of processes, controllability of manufacturing quality, and perfection of specification," and reflect the actual clinical use of drugs in China. In addition, stylistic rules and layout, wording, units, and symbols have all been standardized.

Information and Features

• More than 3,200 drug monographs
• 525 new admissions
• Revisions and additions to Appendices
• New general testing methods
• Revised Guidelines

Contents

• Chinese Materia Medica and Prepared Slices of Chinese Crude Drugs
• Oil, Fats, and Extractives
• Traditional Chinese Patent Medicines and Simple Preparations

• Chemical Drugs
• Antibiotics
• Biochemical Preparations
• Radiopharmaceuticals
• Excipients

• Biological Products

• Membership of the 8th Pharmacopoeia Commission of the People's Republic of China
• Editorial Board
• Preface
• History
• New Admissions
• Omissions or Adjustments
• General Notices
• Appendices
• Index